IBDEI15D ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19518,2)
 ;;=^5009280
 ;;^UTILITY(U,$J,358.3,19519,0)
 ;;=L72.8^^84^918^151
 ;;^UTILITY(U,$J,358.3,19519,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19519,1,3,0)
 ;;=3^Follicular Cysts of Skin/Subcutaneous Tissue NEC
 ;;^UTILITY(U,$J,358.3,19519,1,4,0)
 ;;=4^L72.8
 ;;^UTILITY(U,$J,358.3,19519,2)
 ;;=^5009282
 ;;^UTILITY(U,$J,358.3,19520,0)
 ;;=L72.9^^84^918^152
 ;;^UTILITY(U,$J,358.3,19520,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19520,1,3,0)
 ;;=3^Follicular Cysts of Skin/Subcutaneous Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,19520,1,4,0)
 ;;=4^L72.9
 ;;^UTILITY(U,$J,358.3,19520,2)
 ;;=^5009283
 ;;^UTILITY(U,$J,358.3,19521,0)
 ;;=L73.0^^84^918^3
 ;;^UTILITY(U,$J,358.3,19521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19521,1,3,0)
 ;;=3^Acne Keloid
 ;;^UTILITY(U,$J,358.3,19521,1,4,0)
 ;;=4^L73.0
 ;;^UTILITY(U,$J,358.3,19521,2)
 ;;=^2149
 ;;^UTILITY(U,$J,358.3,19522,0)
 ;;=L73.2^^84^918^159
 ;;^UTILITY(U,$J,358.3,19522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19522,1,3,0)
 ;;=3^Hidradenitis Suppurativa
 ;;^UTILITY(U,$J,358.3,19522,1,4,0)
 ;;=4^L73.2
 ;;^UTILITY(U,$J,358.3,19522,2)
 ;;=^278979
 ;;^UTILITY(U,$J,358.3,19523,0)
 ;;=L73.9^^84^918^153
 ;;^UTILITY(U,$J,358.3,19523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19523,1,3,0)
 ;;=3^Follicular Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,19523,1,4,0)
 ;;=4^L73.9
 ;;^UTILITY(U,$J,358.3,19523,2)
 ;;=^5009286
 ;;^UTILITY(U,$J,358.3,19524,0)
 ;;=L82.0^^84^918^160
 ;;^UTILITY(U,$J,358.3,19524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19524,1,3,0)
 ;;=3^Inflamed Seborrheic Keratosis
 ;;^UTILITY(U,$J,358.3,19524,1,4,0)
 ;;=4^L82.0
 ;;^UTILITY(U,$J,358.3,19524,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,19525,0)
 ;;=L82.1^^84^918^264
 ;;^UTILITY(U,$J,358.3,19525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19525,1,3,0)
 ;;=3^Seborrheic Keratosis NEC
 ;;^UTILITY(U,$J,358.3,19525,1,4,0)
 ;;=4^L82.1
 ;;^UTILITY(U,$J,358.3,19525,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,19526,0)
 ;;=L84.^^84^918^116
 ;;^UTILITY(U,$J,358.3,19526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19526,1,3,0)
 ;;=3^Corns and Callosities
 ;;^UTILITY(U,$J,358.3,19526,1,4,0)
 ;;=4^L84.
 ;;^UTILITY(U,$J,358.3,19526,2)
 ;;=^271920
 ;;^UTILITY(U,$J,358.3,19527,0)
 ;;=L85.0^^84^918^8
 ;;^UTILITY(U,$J,358.3,19527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19527,1,3,0)
 ;;=3^Acquired Ichthyosis
 ;;^UTILITY(U,$J,358.3,19527,1,4,0)
 ;;=4^L85.0
 ;;^UTILITY(U,$J,358.3,19527,2)
 ;;=^5009320
 ;;^UTILITY(U,$J,358.3,19528,0)
 ;;=L85.1^^84^918^10
 ;;^UTILITY(U,$J,358.3,19528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19528,1,3,0)
 ;;=3^Acquired Keratosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,19528,1,4,0)
 ;;=4^L85.1
 ;;^UTILITY(U,$J,358.3,19528,2)
 ;;=^5009321
 ;;^UTILITY(U,$J,358.3,19529,0)
 ;;=L85.2^^84^918^166
 ;;^UTILITY(U,$J,358.3,19529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19529,1,3,0)
 ;;=3^Keratosis Punctata
 ;;^UTILITY(U,$J,358.3,19529,1,4,0)
 ;;=4^L85.2
 ;;^UTILITY(U,$J,358.3,19529,2)
 ;;=^5009322
 ;;^UTILITY(U,$J,358.3,19530,0)
 ;;=L85.3^^84^918^289
 ;;^UTILITY(U,$J,358.3,19530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19530,1,3,0)
 ;;=3^Xerosis Cutis
 ;;^UTILITY(U,$J,358.3,19530,1,4,0)
 ;;=4^L85.3
 ;;^UTILITY(U,$J,358.3,19530,2)
 ;;=^5009323
 ;;^UTILITY(U,$J,358.3,19531,0)
 ;;=L86.^^84^918^164
 ;;^UTILITY(U,$J,358.3,19531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19531,1,3,0)
 ;;=3^Keratoderma in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,19531,1,4,0)
 ;;=4^L86.
 ;;^UTILITY(U,$J,358.3,19531,2)
 ;;=^5009326
 ;;^UTILITY(U,$J,358.3,19532,0)
 ;;=L87.0^^84^918^165
